B-cell Lymphoma

Showing 51 - 75 of 95

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose

Completed
  • B-cell Lymphoma
  • +2 more
  • BI-1206 single agent dose escalation phase
  • +3 more
  • Leicester, England, United Kingdom
  • +4 more
Jun 17, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

Recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
May 21, 2021

B-cell Lymphoma Trial (Fast Dual CAR-T Injection)

Not yet recruiting
  • B-cell Lymphoma
  • Fast Dual CAR-T Injection
  • (no location specified)
May 7, 2021

Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (hCD19.IL15.CAR-iNKT)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Xuzhou, Jiangsu, China
    The Affiliated hospital of Xuzhou medical University
Mar 24, 2021

B-Cell Lymphoma Trial in Beijing (GB241, Rituximab)

Completed
  • B-Cell Lymphoma
  • GB241
  • Rituximab
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 19, 2021

Acute Lymphoblastic Leukemia, Chronic Lymphoblastic Leukemia, B-cell Lymphoma Trial in Wuhan (Fludarabine + Cyclophosphamide +

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
  • Wuhan, Hubei, China
  • +1 more
Mar 11, 2021

Chronic Lymphocytic Leukemia, B-Cell Lymphoma Trial in United States (DTRMWXHS-12, DTRM-505, DTRM-555)

Completed
  • Chronic Lymphocytic Leukemia
  • B-Cell Lymphoma
  • Phoenix, Arizona
  • +5 more
Nov 24, 2020

B-cell Malignancy, B-cell Lymphoma, B-Cell Acute Lymphoblastic Leukaemia Trial in Shanghai (CD19 CAR T)

Recruiting
  • B-cell Malignancy
  • +2 more
  • CD19 CAR T
  • Shanghai, China
    Shanghai Tong Ren hospital
Nov 3, 2020

T-Cell Lymphoma, B-Cell Lymphoma Trial in Worldwide (enzastaurin)

Completed
  • T-Cell Lymphoma
  • B-Cell Lymphoma
  • Anaheim, California
  • +13 more
Sep 23, 2020

B-cell Lymphoma, HBV Trial in Shanghai (Tenofovir, Entecavir)

Recruiting
  • B-cell Lymphoma
  • HBV
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Sep 2, 2020

B-cell Lymphoma Trial in United States (SD-101, Radiation therapy)

Terminated
  • B-cell Lymphoma
  • Stanford, California
  • +4 more
Aug 20, 2020

B-Cell Lymphoma Trial in China (IBI301, Rituximab)

Completed
  • B-Cell Lymphoma
  • Beijing, Beijing, China
  • +11 more
Aug 30, 2020

Lymphoma, B-cell Lymphoma Trial in Houston (Leukapheresis, Stem Cell Transplant, CD19-specific T Cell Infusion)

Completed
  • Lymphoma
  • B-cell Lymphoma
  • Leukapheresis
  • +7 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

B-cell Lymphoma Trial in Essen (Lenalidomide)

Completed
  • B-cell Lymphoma
  • Essen, Germany
    Klinik für Hämatologie, Universitätsklinikum Essen
Feb 25, 2020

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in ChongQing (anti-CD19 UCAR-T cells, Fludarabine, Cytoxan)

Unknown status
  • B-cell Acute Lymphoblastic Leukemia
  • B-cell Lymphoma
  • anti-CD19 UCAR-T cells
  • +3 more
  • ChongQing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Feb 7, 2020

Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States

Completed
  • Relapsed or Refractory Lymphoproliferative Malignancies
  • +4 more
  • Pralatrexate Injection
  • +3 more
  • Los Angeles, California
  • +14 more
Dec 27, 2019

Marginal Zone Lymphoma, B-cell Lymphoma Trial in Worldwide (ibrutinib)

Completed
  • Marginal Zone Lymphoma
  • B-cell Lymphoma
  • Tucson, Arizona
  • +24 more
Oct 8, 2019

Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia Trial in United States (Ublituximab)

Completed
  • Non-Hodgkins Lymphoma
  • +6 more
  • Huntsville, Alabama
  • +7 more
Oct 1, 2019

B-cell Lymphoma Trial in Beijing, Hangzhou (AC0010MA)

Unknown status
  • B-cell Lymphoma
  • Beijing, Beijing, China
  • +1 more
Jan 31, 2019

B-cell Lymphoma Trial in Belgium, France (Ibrutinib and immunochemotherapies)

Terminated
  • B-cell Lymphoma
  • Ibrutinib and immunochemotherapies
  • Bruxelles, Belgium
  • +14 more
Oct 9, 2018

Lymphoma, B-cell Lymphoma, Non Hodgkin Lymphoma Trial in Baltimore (drug, radiation, biological)

Terminated
  • Lymphoma
  • +3 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 26, 2018

Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive

Unknown status
  • B-cell Lymphoma
    • Seoul, Korea, Republic of
      Severance Hospital
    Jul 15, 2018

    B-cell Lymphoma Trial in Nantes (90Y-DOTA-hLL2)

    Terminated
    • B-cell Lymphoma
    • Nantes, France
      Chu/Clcc Nantes
    Apr 26, 2018

    B-Cell Lymphoma Trial in Worldwide (inotuzumab ozogamicin, Rituximab)

    Completed
    • B-Cell Lymphoma
    • Birmingham, Alabama
    • +37 more
    Feb 6, 2018